Comparison of survival in patients with end-stage renal disease receiving hemodialysis versus peritoneal dialysis
المؤلفون المشاركون
Hayati, Fatimah
Mousavi, Sayyid Sayf Allah Beladi
Mousavi, Marzieh Beladi
Rikabi, Fadl Allah
Valavi, Ihsan
المصدر
Saudi Journal of Kidney Diseases and Transplantation
العدد
المجلد 26، العدد 2 (30 إبريل/نيسان 2015)، ص ص. 392-397، 6ص.
الناشر
تاريخ النشر
2015-04-30
دولة النشر
السعودية
عدد الصفحات
6
التخصصات الرئيسية
الموضوعات
الملخص EN
Although the life expectancy of patients with end-stage renal disease (ESRD) has improved in recent years, it is still far below that of the general population.
In this retrospective study, we compared the survival of patients with ESRD receiving hemodialysis (HD) versus those on peritoneal dialysis (PD).
The study was conducted on patients referred to the HD and PD centers of the Emam Khomini Hospital and the Aboozar Children’s Hospital from January 2007 to May 2012 in Ahvaz, Iran.
All ESRD patients on maintenance HD or PD for more than two months were included in the study.
The survival was estimated by the Kaplan-Meier method and the differences between HD and PD patients were tested by the log-rank test.
Overall, 239 patients, 148 patients on HD (61.92 %) and 91 patients on continuous ambulatory PD (CAPD) (38.55 %) with mean age of 54.1 ± 17 years were enrolled in the study.
Regardless of the causes of ESRD and type of renal replacement therapy (RRT), one-, two- and three-year survival of patients was 65 %, 51 % and 35 %, respectively.
There was no significant difference between type of RRT in one- (P-value = 0.737), two- (P-value = 0.534) and three- (P-value = 0.867) year survival.
There was also no significant difference between diabetic and non-diabetic patients under HD and CAPD in the one-, two- and three-year survival.
Although the three-year survival of diabetic patients under CAPD was lower than that of non-diabetic patients (13 % vs.
34 %), it was not statistically significant (P-value = 0.50).
According to the results of the current study, there is no survival advantage of PD during the first years of initiation of dialysis, and the one-, two- and three-year survival of HD and PD patients is also similar.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Mousavi, Sayyid Sayf Allah Beladi& Hayati, Fatimah& Valavi, Ihsan& Rikabi, Fadl Allah& Mousavi, Marzieh Beladi. 2015. Comparison of survival in patients with end-stage renal disease receiving hemodialysis versus peritoneal dialysis. Saudi Journal of Kidney Diseases and Transplantation،Vol. 26, no. 2, pp.392-397.
https://search.emarefa.net/detail/BIM-532764
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Valavi, Ihsan…[et al.]. Comparison of survival in patients with end-stage renal disease receiving hemodialysis versus peritoneal dialysis. Saudi Journal of Kidney Diseases and Transplantation Vol. 26, no. 2 (2015), pp.392-397.
https://search.emarefa.net/detail/BIM-532764
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Mousavi, Sayyid Sayf Allah Beladi& Hayati, Fatimah& Valavi, Ihsan& Rikabi, Fadl Allah& Mousavi, Marzieh Beladi. Comparison of survival in patients with end-stage renal disease receiving hemodialysis versus peritoneal dialysis. Saudi Journal of Kidney Diseases and Transplantation. 2015. Vol. 26, no. 2, pp.392-397.
https://search.emarefa.net/detail/BIM-532764
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 396-397
رقم السجل
BIM-532764
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر